COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations
Michael P. Lunn, David R. Cornblath, Bart C. Jacobs, Luís Querol, P.A. van Doorn, Richard AC Hughes, Hugh J. Willison
Abstract
This special commentary refers to ‘Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome’ by Keddie et al. (doi:10.1093/brain/awaa433).
Topics & Concepts
Guillain-Barre syndromeCoronavirus disease 2019 (COVID-19)EpidemiologyMedicine2019-20 coronavirus outbreakCohortVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cohort studyPediatricsOutbreakPathologyDiseaseInfectious disease (medical specialty)Peripheral Neuropathies and DisordersLong-Term Effects of COVID-19Hereditary Neurological Disorders